{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T12:52:39.160646+00:00","published_at":"2026-10-19T04:46:40.733122+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:tfihvq11zrjvw","event_type":"CFO_CHANGED","effective_at":"2026-03-06","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:gregory-weaver","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:fb4a5163996c2879adc742e207969dcb215b6c50d48b05dc98c8394713012467"],"summary":"Gregory Weaver executive of Altimmune, Inc., effective 2026-03-06.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18g7gd8198cods","event_type":"CEO_CHANGED","effective_at":"2026-03-06","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:jerome-durso","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:30b2b22e9142c1e653cbc866eab0f0e073f4226fa9c095aff2e4669d9f9de6d6"],"summary":"Jerome Durso executive of Altimmune, Inc., effective 2026-03-06.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cw2u8v1qb9377","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:jerome-durso-2","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Jerome Durso seat on Altimmune, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hp81n7dyw31j","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:teri-lawver","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Teri Lawver seat on Altimmune, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bqcko7el9kev","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:catherine-sohn-pharm-d","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Catherine Sohn, Pharm D. seat on Altimmune, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zaqp9p27w2dn","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:committee:altimmune-inc:compensation-chair-nominating-and-governance","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Compensation · Chair; Nominating and Governance committee of Altimmune, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1iqvjyz5la23r","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:catherine-sohn-pharm-d","alpha:committee:altimmune-inc:compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Catherine Sohn, Pharm D. member of Compensation · Chair; Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j81aj917s4tn","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:diane-jorkasky-m-d","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Diane Jorkasky, M.D. seat on Altimmune, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x2mgf4124gjag","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:wayne-pisano","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Wayne Pisano seat on Altimmune, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ot4mo21a0ksho","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:committee:altimmune-inc:nominating-and-governance-chair","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Nominating and Governance · Chair committee of Altimmune, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qq6zl1fsp0xd","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:wayne-pisano","alpha:committee:altimmune-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Wayne Pisano member of Nominating and Governance · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b7va6woomvpo","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:klaus-o-schafer-m-d-mph","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Klaus O. Schafer, M.D., MPH seat on Altimmune, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1w2uow717w4goh","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:philip-l-hodges","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Philip L. Hodges seat on Altimmune, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jo9nvbdxdagx","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:committee:altimmune-inc:audit-chair-compensation","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Audit · Chair; Compensation committee of Altimmune, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11dx0jf1jiuo6z","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:philip-l-hodges","alpha:committee:altimmune-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Philip L. Hodges member of Audit · Chair; Compensation, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:z9n1et8sj2fj","event_type":"DIRECTOR_APPOINTED","effective_at":"2010-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:mitchel-sayare-ph-d","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Mitchel Sayare, Ph.D. seat on Altimmune, Inc., effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mrww871vaw47z","event_type":"DIRECTOR_APPOINTED","effective_at":"2004-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:john-m-gill","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"John M. Gill seat on Altimmune, Inc., effective 2004-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1oghfvf1emb4rr","event_type":"COMMITTEE_CREATED","effective_at":"2004-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:committee:altimmune-inc:audit-nominating-and-governance","alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"Audit; Nominating and Governance committee of Altimmune, Inc., effective 2004-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13e3tau67ttzu","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2004-01-01","detected_at":"2026-10-19T04:46:40.733122+00:00","subject_ids":["alpha:person:john-m-gill","alpha:committee:altimmune-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8"],"summary":"John M. Gill member of Audit; Nominating and Governance, effective 2004-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:5","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:catherine-sohn-pharm-d","object_label":"Catherine Sohn, Pharm D.","object_source_name_forms":[],"value":"Catherine Sohn, Pharm D.: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:catherine-sohn-pharm-d","name":"Catherine Sohn, Pharm D."},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:6","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diane-jorkasky-m-d","object_label":"Diane Jorkasky, M.D.","object_source_name_forms":[],"value":"Diane Jorkasky, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diane-jorkasky-m-d","name":"Diane Jorkasky, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:7","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jerome-durso-2","object_label":"Jerome Durso","object_source_name_forms":[],"value":"Jerome Durso: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jerome-durso-2","name":"Jerome Durso"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:8","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-m-gill","object_label":"John M. Gill","object_source_name_forms":[],"value":"John M. Gill: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-m-gill","name":"John M. Gill"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2004-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2004-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2004-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:9","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:klaus-o-schafer-m-d-mph","object_label":"Klaus O. Schafer, M.D., MPH","object_source_name_forms":[],"value":"Klaus O. Schafer, M.D., MPH: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:klaus-o-schafer-m-d-mph","name":"Klaus O. Schafer, M.D., MPH"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:10","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mitchel-sayare-ph-d","object_label":"Mitchel Sayare, Ph.D.","object_source_name_forms":[],"value":"Mitchel Sayare, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mitchel-sayare-ph-d","name":"Mitchel Sayare, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:11","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:philip-l-hodges","object_label":"Philip L. Hodges","object_source_name_forms":[],"value":"Philip L. Hodges: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:philip-l-hodges","name":"Philip L. Hodges"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:12","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:teri-lawver","object_label":"Teri Lawver","object_source_name_forms":[],"value":"Teri Lawver: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:teri-lawver","name":"Teri Lawver"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:13","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:wayne-pisano","object_label":"Wayne Pisano","object_source_name_forms":[],"value":"Wayne Pisano: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:wayne-pisano","name":"Wayne Pisano"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:14","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:gregory-weaver","object_label":"Gregory Weaver","object_source_name_forms":[],"value":"Gregory Weaver: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:gregory-weaver","name":"Gregory Weaver"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-06","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-06","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:fb4a5163996c2879adc742e207969dcb215b6c50d48b05dc98c8394713012467","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000018/alt-20251231x10k.htm","source_date":"2026-03-06T00:00:00+00:00","retrieved_at":"2026-05-04T22:09:24.53925+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-06T00:00:00+00:00","effective_from":"2026-03-06","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ce7aa889-cc32-4291-9a76-a6af241d6082:leadership_role:15","subject_id":"alpha:company:ce7aa889-cc32-4291-9a76-a6af241d6082","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jerome-durso","object_label":"Jerome Durso","object_source_name_forms":[],"value":"Jerome Durso: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jerome-durso","name":"Jerome Durso"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-06","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-06","valid_to":null,"recorded_at":"2026-10-19T04:46:40.733122+00:00","sources":[{"id":"alpha:projection-evidence:document:30b2b22e9142c1e653cbc866eab0f0e073f4226fa9c095aff2e4669d9f9de6d6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000018/alt-20251231x10k.htm","source_date":"2026-03-06T00:00:00+00:00","retrieved_at":"2026-05-04T22:09:23.988523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-06T00:00:00+00:00","effective_from":"2026-03-06","effective_until":null,"observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:3e544326b6181e3c0a0c7be820d44d5eab2f77d8bb1bc2d081e3fb9db7a339b8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Altimmune, Inc. DEF 14A 2026-03-17","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465926028953/alt-20260416xdef14a.htm","source_date":"2026-03-17","retrieved_at":"2026-04-24T16:07:00.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fb4a5163996c2879adc742e207969dcb215b6c50d48b05dc98c8394713012467","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000018/alt-20251231x10k.htm","source_date":"2026-03-06T00:00:00+00:00","retrieved_at":"2026-05-04T22:09:24.53925+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:30b2b22e9142c1e653cbc866eab0f0e073f4226fa9c095aff2e4669d9f9de6d6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000018/alt-20251231x10k.htm","source_date":"2026-03-06T00:00:00+00:00","retrieved_at":"2026-05-04T22:09:23.988523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.839,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.579},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T04:46:40.733122+00:00","observed_at":"2026-10-19T04:46:40.733122+00:00","reviewed_at":"2026-10-19T04:46:40.733122+00:00","verified_at":"2026-10-19T04:46:40.733122+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/altimmune-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/altimmune-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}